118 related articles for article (PubMed ID: 1695170)
1. Effect of AML serum on normal human myeloid differentiation and hexamethylene bisacetamide-induced granulocytic differentiation of the human HL-60 promyelocytic leukaemic cell line.
Hassan HT; Rees JK
Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(1):151-9. PubMed ID: 1695170
[TBL] [Abstract][Full Text] [Related]
2. Induction of differentiation of human promyelocytic leukemia cells (HL60) by metabolites of hexamethylene bisacetamide.
Snyder SW; Egorin MJ; Geelhaar LA; Hamburger AW; Callery PS
Cancer Res; 1988 Jul; 48(13):3613-6. PubMed ID: 3163938
[TBL] [Abstract][Full Text] [Related]
3. Induction of differentiation in human myeloid leukemic cells by proteolytic enzymes.
Fibach E; Treves A; Kidron M; Mayer M
J Cell Physiol; 1985 May; 123(2):228-34. PubMed ID: 3884635
[TBL] [Abstract][Full Text] [Related]
4. New facts and speculations on human myeloid leukemias.
Breitman TR; Gallo RC
Blood Cells; 1981; 7(1):79-89. PubMed ID: 6964818
[TBL] [Abstract][Full Text] [Related]
5. Changes in glycosphingolipid composition during differentiation of human leukemic granulocytes in chronic myelogenous leukemia compared with in vitro granulocytic differentiation of human promyelocytic leukemia cell line HL-60.
Nojiri H; Takaku F; Ohta M; Miura Y; Saito M
Cancer Res; 1985 Dec; 45(12 Pt 1):6100-6. PubMed ID: 3864527
[TBL] [Abstract][Full Text] [Related]
6. Expression of leukocyte adherence-related glycoproteins during differentiation of HL-60 promyelocytic leukemia cells.
Hickstein DD; Smith A; Fisher W; Beatty PG; Schwartz BR; Harlan JM; Root RK; Locksley RM
J Immunol; 1987 Jan; 138(2):513-9. PubMed ID: 2947951
[TBL] [Abstract][Full Text] [Related]
7. HIC1 tumour suppressor gene is suppressed in acute myeloid leukaemia and induced during granulocytic differentiation.
Britschgi C; Jenal M; Rizzi M; Mueller BU; Torbett BE; Andres AC; Tobler A; Fey MF; Tschan MP
Br J Haematol; 2008 Apr; 141(2):179-87. PubMed ID: 18318772
[TBL] [Abstract][Full Text] [Related]
8. Retinoic acid-induced monocytic differentiation of HL60/MRI, a cell line derived from a transplantable HL60 tumor.
Imaizumi M; Uozumi J; Breitman TR
Cancer Res; 1987 Mar; 47(5):1434-40. PubMed ID: 3469018
[TBL] [Abstract][Full Text] [Related]
9. Identification of a regulatory peptide distinct from normal granulocyte-derived hemoregulatory peptide produced by human promyelocytic HL-60 leukemia cells after differentiation induction with retinoic acid.
Paukovits JB; Paukovits WR; Laerum OD
Cancer Res; 1986 Sep; 46(9):4444-8. PubMed ID: 3460696
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of growth but not differentiation of normal and leukemic myeloid cells by methylthioadenosine.
Riscoe MK; Schwamborn J; Ferro AJ; Olson KD; Fitchen JH
Cancer Res; 1987 Jul; 47(14):3830-4. PubMed ID: 3474063
[TBL] [Abstract][Full Text] [Related]
11. [Influence of patients' sera in acute leukemia on proliferation and differentiation of K-562 and HL-60 cells in liquid culture].
Kuliczkowski K
Acta Haematol Pol; 1994; 25(2):171-7. PubMed ID: 8067189
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of CD44 contributes to the differentiation of HL-60 cells induced by ATRA or HMBA.
Liu J; Bi G; Wen P; Yang W; Ren X; Tang T; Xie C; Dong W; Jiang G
Cell Mol Immunol; 2007 Feb; 4(1):59-63. PubMed ID: 17349212
[TBL] [Abstract][Full Text] [Related]
13. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of myeloid cells in liquid culture: 2. Acute myelocytic leukemia cells.
Archimbaud E; Preisler HD
Cell Biochem Funct; 1987 Jul; 5(3):157-66. PubMed ID: 3475187
[TBL] [Abstract][Full Text] [Related]
15. [Differentiation induction of myeloid leukemia cells by glucocorticoid--the differentiation induction effect in vitro and in vivo].
Nakamaki T; Sakashita A; Sano M; Hino K; Suzuki K; Tomoyasu S; Tsuruoka N
Rinsho Ketsueki; 1989 Feb; 30(2):149-57. PubMed ID: 2746870
[TBL] [Abstract][Full Text] [Related]
16. Combinations of retinoic acid with either sodium butyrate, dimethyl sulfoxide, or hexamethylene bisacetamide synergistically induce differentiation of the human myeloid leukemia cell line HL60.
Breitman TR; He RY
Cancer Res; 1990 Oct; 50(19):6268-73. PubMed ID: 2400989
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human interferon alpha enhancement of retinoic-acid-induced differentiation of HL-60 cells.
Kohlhepp EA; Condon ME; Hamburger AW
Exp Hematol; 1987 May; 15(4):414-8. PubMed ID: 3471521
[TBL] [Abstract][Full Text] [Related]
18. Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-alpha.
Drach J; McQueen T; Engel H; Andreeff M; Robertson KA; Collins SJ; Malavasi F; Mehta K
Cancer Res; 1994 Apr; 54(7):1746-52. PubMed ID: 7511050
[TBL] [Abstract][Full Text] [Related]
19. Interferon-alpha and -gamma promote myeloid differentiation of HL-60, a human acute promyelocytic leukemia cell line.
Buessow SC; Gillespie GY
J Biol Response Mod; 1984 Dec; 3(6):653-62. PubMed ID: 6439829
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of retinoic acid-induced differentiation of human acute promyelocytic leukemia NB4 cells by butyric acid, tributyrin, and hexamethylene bisacetamide.
Taimi M; Chen ZX; Breitman TR
Oncol Res; 1998; 10(2):75-84. PubMed ID: 9666515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
